Peter J. Hotez, MD, PhD; K. M. Venkat Narayan, MD
free access
JAMA. 2021;325(23):2337-2338. doi:10.1001/jama.2021.7439
This Viewpoint discusses the importance of equitable international collaboration, innovative manufacturing and supply chain development, and shared governance to provide the billions of COVID-19 vaccine doses to the world鈥檚 low-income and low-resource populations that will be necessary to control the coronavirus pandemic.
Carlos Blanco, MD, PhD; Melanie M. Wall, PhD; Mark Olfson, MD, MPH
JAMA. 2021;325(23):2339-2340. doi:10.1001/jama.2021.6678
This Viewpoint discusses the prospect that suicide prevention interventions at a population level could complement gains from individual-level approaches and help reverse the high toll of suicide in the US.
Humayun J. Chaudhry, DO, MS; Cheryl Walker-McGill, MD, MBA; Victor J. Dzau, MD
JAMA. 2021;325(23):2341-2342. doi:10.1001/jama.2021.6694
This Viewpoint describes the connections between the US opioid use disorder (OUD) epidemic and crises in health care workforce well-being and describes a collaboration between the National Academy of Medicine (NAM) and Federation of State Medical Boards (FSMB) to address both and harmonize regulatory standards and practices where possible.
John W. Beasley, MD; Richard G. Roberts, MD, JD; Allan H. Goroll, MD
JAMA. 2021;325(23):2343-2344. doi:10.1001/jama.2021.6046
This Viewpoint discusses the origins of the term provider as a reference to health care professionals, considers unintentional and potentially detrimental consequences of its use, and recommends replacement of the term with precise and respectful language that specifies the titles, roles, and responsibilities of people interacting with patients in health care settings.